August 3rd, 2011
Podcast 127: Why QALYs matter
This time we talk with Dr. Katia Noyes, first author on a study of the cost-effectiveness of disease-modifying drugs in multiple sclerosis. If you don’t treat MS, don’t think that the topic is irrelevant. Noyes brings the issues of cost-effectiveness and the dreaded QALY into focus for clinicians who see patients. After all, medical costs will […]
January 29th, 2010
Podcast 72: A conversation about two new drugs for multiple sclerosis.
We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease. Interview-story link: MS Treatments Said […]
October 31st, 2008
Podcast 18: News plus an interview with Prof. Riccardo Utili about infective endocarditis in the elderly
This week we look at why infective endocarditis among the elderly has characteristics very different from its manifestations in younger patients. Prof. Riccardo Utili of the Second University of Naples is our guest. And of course we start with a brief news roundup. Journal Watch links: Breast Cancer Less Likely to Recur in Women with […]
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
